Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Fibrous Dysplasia
NCT03571191Phase 2Active, not recruiting
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Jun 2019
- Primary completion
- Nov 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in fibrous dysplasia, sponsored by National Institute of Dental and Craniofacial Research. Started Jun 2019; status: active, not recruiting.
02
Drugs
denosumab
03
Conditions
fibrous dysplasia
Beyond the preview
Go deeper on NCT03571191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03571191.